GENE ONLINE|News &
Opinion
Blog

Special
COVID-19 Moderna
Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel
2022-05-23
Special
The First International Biomedical Entrepreneurship Competition Has Announced Its Top 6 Winners
2022-05-23
Special ASGCT
RNA Therapeutics Beyond Vaccines
2022-05-19
Feature Healthcare Industry
Financial Times’ US Pharma Biotech Summit 2022: Track & Invest in American Life Sciences
2022-05-16
Go Prime Cannabidiol
The FDA Issued its First Formal Warning to Companies Selling Delta-8 THC Products
2022-05-05
Special ACT Genomics
APCM 2022: Precision Medicine Is Opening Up a New Prospect of Cancer Therapy
2022-05-04Partner
Deals Oncology
All Blue Capital Recruits Former AstraZeneca Oncology Head to Sweeten Zymeworks Deal
2022-05-04
Special Antibiotics
Spero Therapeutic Lays Off 75% of Employees Resulting in Stock Plummet
2022-05-04
Deals Eye Development
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
Special 2022 psychedelics
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
Special AACR
AACR 2022: Raising Capital for Drugs of the Future- Cell Therapies
2022-04-18
Special Single Cell Sequencing
Single Cell Sequencing Uncovers How Early Embryonic Cells Differentiate
2022-04-13
Interviews 2022 psychedelics
The Renaissance of Psychedelics Research: An Interview with the CEO of MindMed, Rob Barrow
2022-04-12
Special 2022 Digital Health
How to Break into the Digital Health Market in the UK – An Interview with Professor Sudhesh Kumar
2022-03-25
Special 2022 psychedelics
WSJ Health Forum 2022: Psychedelics Set to Take Center Stage in Mental Wellness
2022-03-24
1 … 10 11 12 13 14 … 20
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top